Royse Law Firm provides transactional tax, business and corporate law services to emerging growth and middle market companies as well as to private equity, angel and venture funds. Our clients include companies in the technology and alternative energy sectors as well as more traditional businesses. We frequently advise other law firms on various tax aspects. We are experienced in the negotiation of M&A, corporate equity and debt financing, and partnership and joint venture transactions.
Laurie A. Allen has represented technology driven companies for 20 years in the areas of corporate, securities, tax and intellectual property. Her primary focus has been in the fields of pharmaceuticals, biotechnology, health care, medical devices and information technologies. Laurie’s clients have ranged from venture-backed start-ups to publically traded multinational corporations, where she has acted as lead counsel in public and private financings, mergers and acquisitions, venture capital fund formation and investments, joint ventures, corporate partnering and management of strategic alliance relationships, intellectual property licensing, strategy and management of sophisticated patent litigation, as well as other general corporate matters.Laurie has significant experience advising corporate boards with respect to their duties and best corporate governance practices. Prior to joining the Royse Law Firm, she served as the general counsel of two publically traded companies (Alexandria Real Estate Equities, Inc./NYSE: ARE and ARIAD Pharmaceuticals, Inc./NASDAQ: ARIA) and was a partner in the Business and Technology Group and Life Sciences Practice of the law firm of Brobeck, Phleger & Harrison LLP (formerly one of the nation’s leading technology law firms). Laurie is a member of the American Bar and California Bar Associations, where she is a member of the Business Law and Intellectual Property Law Sections.
Congress noticed that more and more prescription drugs and medical equipment was being manufactured overseas prior to being sold in America. In this article, Laurie Allen writes about The Drug and Device Accountability Act of 2009, which gives...
March 8, 2011
The FDA is the regulator in charge of approving new pharmaceutical drugs before they hit the market. The GAO is the government agency responsible for auditing the practices of other government regulators. In this article, Laurie Allen...
No clients exist for this lawyer.
Asked in California | Startup Law | 455 days ago
Royse Law Firm, PC
10900 Wilshire Blvd., Suite 300